. Afferent input from rat slow skeletal muscle inhibits bioassayable growth hormone release. J. Appl. Physiol. 88: 142-148, 2000.-The release of a bioassayable form of growth hormone (BGH), distinct from growth hormone as measured by immunoassay (IGH), from the rat pituitary into the blood is differentially regulated by afferent input from fast and slow skeletal muscles. Specifically, activation of low-threshold fast muscle afferents for 15 min increased plasma BGH by 217 and 295% and decreased pituitary BGH by 68 and 45% in male and female rats, respectively. In contrast, activation of slow muscle afferents inhibited BGH release, decreasing plasma BGH by ϳ60% and increasing pituitary BGH by 30-50% in male rats. Female rats from which food had been withheld for ϳ12 h had elevated basal plasma BGH levels, which then were decreased by 81% after slow muscle nerve stimulation. Plasma IGH concentrations were unchanged after any nerve stimulation condition. These results demonstrate that regulation of BGH release can be differentially mediated through low-threshold afferent inputs from fast or slow skeletal muscle. Furthermore, the results indicate that BGH responses are independent of gender or feeding status.
immunoassay; bioassay; proprioception; electrical stimulation; peripheral nerves; low-threshold afferents MULTIPLE MOLECULAR FORMS of growth hormone (GH), ranging from 5 to 100 kDa in size and possessing varied physiological actions, recently have been demonstrated in human plasma and in rat plasma and pituitary tissue (3) . However, GH measurements most often are determined by using immunoassays that recognize primarily the 22-kDa form of GH (IGH). It generally is recognized that exercise elevates IGH in humans (25) , although no response has been observed in exercised rats (6) . The existence of multiple GH forms along with the presence of two binding proteins, one receptor related with high affinity for IGH and one with low affinity, which circulate in plasma and are capable of further modifying IGH action (3) , suggests that measurement of IGH alone likely does not provide a complete profile of GH at rest or in response to exercise.
Our laboratories have previously shown that another form of GH, measurable by bioassay (BGH), is released in response to sensory afferent input from fast skeletal muscles in rats (14, 15, 17) . In the present study, we have continued to examine the mechanisms by which muscle activity could modulate BGH.
The evidence that there are alternative forms of GH, measurable by bioassay but not detectable by immunoassay, is substantial (9-11, 15, 21, 29) . Fractionation studies have shown that a 60-to 80-kDa peptide is released from pituitary somatotrophs, both constitutively and in response to extrapituitary stimuli that stimulates tibial epiphyseal growth in a dose-dependent fashion (9) (10) (11) . To date, BGH has been found in human (9, 11, 29) , bovine (11) , cat (unpublished observations), and rat (9) (10) (11) (14) (15) (16) (17) plasma as well as in the anterior pituitary of rats (9-11, 14-17, 21) . Although the mechanism(s) for regulating BGH secretion have not been identified, basal levels of BGH are reduced after spaceflight in rats (21) and the normal exerciseinduced increase in BGH is inhibited during bed rest in humans (29) , suggesting a link between the level of proprioceptive input and the secretion of BGH.
We have reported previously that 15-min bouts of electrical stimulation of the proximal ends of severed nerves innervating predominantly fast muscle (such as the tibial nerve) increase BGH release in anesthetized male rats (15) . Furthermore, this response was specific to BGH in that no changes were seen in IGH nor in any other plasma hormones (e.g., testosterone, thyroid hormones, and corticosterone) or metabolites (e.g., glucose, lactate, and triglycerides) measured. The stimulation intensity was of sufficient strength (2 times threshold) to excite group I and possibly group II afferent nerve fibers but was insufficient to excite the higher threshold group III or IV afferents. The BGH response in these experiments, therefore, seemed to be mediated by afferent inputs from muscle spindles and/or possibly Golgi tendon organs.
The present study was designed to test the hypothesis that the same stimulation protocol administered to the soleus nerve, innervating only the slow soleus muscle, which has the highest spindle density of any major hindlimb muscle, will elicit a BGH response similar to that seen after stimulation of the tibial nerve. Because the tibial nerve trunk stimulated in the previous experiment (15) also includes the soleus nerve
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trunk, the present experiment separates the relative role of afferent input from fast and slow muscle. To further test the generality of these muscle afferent effects, and given that there are gender-dependent differences in the regulation of IGH in rats (8) , we compared the responses to stimulation of the proximal end of the severed tibial or soleus nerve in male and female rats. We also tested the robustness of the neuroregulatory effects under conditions when the metabolic state of the rats was perturbed. It has been demonstrated previously that food deprivation in rats depletes pituitary BGH and elevates plasma BGH by approximately threefold (10, 11) but does not affect plasma IGH concentrations (10) . We wanted to determine, therefore, whether the nerve stimulation effects were maintained after alteration of baseline BGH secretion by ϳ12 h of food deprivation. Similar effects of nerve stimulation were observed regardless of gender or the metabolic state of the rats.
METHODS
Experimental animals. Male (354 Ϯ 4 g) and female (269 Ϯ 4 g) rats (Taconic Sprague Dawley, Germantown, NY) were housed in shoebox cages in a 25 Ϯ 1°C room with a reversed 12:12-h light-dark cycle. All male rats and two groups of female rats were given water and food (Purina rat chow) ad libitum; the remaining four groups of female rats had food withheld for ϳ12 h before the in situ experiment. After shipment, rats were given at least 1 wk to acclimatize before experimentation. Animal care and use were in accordance with the Guidelines of the National Institutes of Health and were approved by the Institutional Animal Care and Use Committee.
Stimulation protocol. Peripheral hindlimb (soleus, tibial, or sural) nerves were isolated and severed in surgically anesthetized (pentobarbital sodium, 50 mg/kg ip) rats (n ϭ 3-10/group). The nerves were chosen on the basis of the tissue they innervate: 1) the soleus nerve innervates only the predominantly slow soleus muscle, 2) the tibial nerve innervates all of the posterior calf and plantar foot muscles (predominantly fast muscles and the soleus), and 3) the sural nerve is largely cutaneous and has extremely limited muscle innervation. The proximal ends of the severed nerves were placed on a bipolar silver electrode and stimulated in situ with a 20-µs square-wave pulse for 15 min at a train frequency simulating electromyographic patterns recorded from rats running on a treadmill at 40 m/min (100 Hz, 150 ms on:150 ms off) (31) . Current strength was two times the threshold required to elicit a visible reflex response. This stimulation level was of sufficient strength to stimulate group I and II afferents from primary and secondary muscle spindle endings and/or Golgi tendon organs and well below the level at which group III and IV afferents are excited (i.e., 5 times threshold or greater; Ref. 28 ). This recruitment pattern was verified in a separate experiment where antidromic compound action potentials were recorded from the sciatic nerve while the tibial nerve was stimulated (Fig. 1) . The recruitment of group I (conduction velocity ϭ 57 Ϯ 1.8 m/s) and II (conduction velocity ϭ 27 Ϯ 0.9 m/s) afferents was readily evident at stimulation strengths ranging from 1 to 7 V, whereas no evidence of group III or IV afferents was apparent at these strengths. These conduction velocities for group I and II fibers are in agreement with those previously reported in the literature (32) . Control rats underwent the same anesthetic and surgical manipulations but were not stimulated.
Sample collection. After the 15-min experimental paradigm, all rats were decapitated after being bled by cardiac puncture by using heparin sodium as an anticoagulant. Pituitary glands were cleanly dissected from the sella turcica, and the anterior lobes were pooled by group and frozen at Ϫ70°C. Later, the glands were thawed, weighed, and homogenized with an all-glass hand homogenizer in a small volume of 0.01 M Na 2 CO 3 ; the homogenate was diluted for bioassay with 0.85% NaCl. After centrifugation of the heparinized blood (1,500 g, 30 min, 4°C), an aliquot of plasma from each rat was drawn off and stored at Ϫ70°C with sodium fluoride as a preservative. The remaining plasma from each rat was combined into a single pooled sample for each experimental group and stored without preservatives at Ϫ70°C until assayed for BGH. In individual rat plasma samples, plasma IGH was measured by using an in-house immunoassay described in IGH and BGH assays, whereas commercially available kits were used for measurement of other plasma hormones (inter-and intra-assay coefficients of variation were Ͻ10% for each assay). 3,5,3ЈTriiodothyronine (T 3 ), thyroxine (T 4 ), and testosterone were measured by using a solid-phase immunoassay (Diagnostic Products, Los Angeles, CA) and corticosterone was measured using a doubleantibody immunoassay (ICN Biomedicals, Costa Mesa, CA). Plasma metabolites (lactate, glucose, triglycerides) were measured with an automated analyzer (COBAS; Roche Diagnostics, Montclair, NJ).
IGH and BGH assays. A variation of the double-antibody procedure of Schalch and Reichlin (33) was used to measure IGH. The rat GH (VII-38-C; 3 IU/mg), used for immunization, standardization of the immunoassays, and labeling, was produced in house as was the primary antiserum. The hormone was labeled with 125 I according to the method of Hunter and Greenwood (20) . The primary antibody (monkey anti-rat GH; V-30-G1) was used at a 1:250,000 final dilution, and a goat anti-monkey gamma globulin (1:20) was used as the secondary antibody (Antibodies, Davis, CA). Inter-and intra-assay coefficients of variation for this assay were ϳ6 and 4%, respectively.
Bioassays for BGH were conducted following the method of Greenspan et al. (16) . Female rats were hypophysectomized (parapharyngeal approach) at 26 days of age, and the assays were started 2 wk later. The assay animals were injected intraperitoneally once daily for 4 days (2 ml total volume per rat) with hormone standards or unknowns [pooled plasma Fig. 1 . Compound action potential recorded from rat sciatic nerve while antidromically stimulating the ipsilateral tibial nerve. Increasing stimulus voltages were employed, demonstrating that recruitment of group I (first peak; conduction velocity ϭ 57 Ϯ 1.8 m/s) and group II (second peak; conduction velocity ϭ 27 Ϯ 0.9 m/s), but not group III or IV, afferent fibers was achieved at the voltages employed in our studies.
and pituitary homogenates ( 1 ⁄3 and 1 ⁄9 mg tissue/ml) from our experimental animals]. The standard (bovine pituitary GH, XIV-44-C5, 1.5 IU/mg) was produced in house, calibrated against a US Pharmacopeia preparation, and delivered in total doses of 0 (saline), 1.67, 5, 15, and 45 µg/rat. Plasma samples were assayed at a single dose level, and pituitary homogenates were assayed at two dose levels. Bioassay rats were killed by CO 2 overdose ϳ24 h after the final injection, and one tibia was dissected, split longitudinally, and stained with AgNO 3 so that the proximal growth plate could be visualized. Ten measurements were taken across each epiphysis, by using an ocular micrometer mounted on a standard light microscope, and averaged for each rat. Group means then were compared against the generated standard curve. Concentrations of BGH were expressed relative to the growthpromoting activity of the standard rat GH (IGH) reference preparation. The coefficient of variation within bioassays was ϳ3.2%.
Statistical methods. Plasma metabolite and hormone measurements other than BGH were analyzed by using a one-way analysis of variance to determine overall differences, followed by a Tukey-Kramer post hoc test to determine group differences (SuperAnova; Abacus Concepts, Berkeley, CA). Statistical power calculations were Ն80% for all comparisons between experimental groups. Pituitary BGH measurements (2 dose levels) were determined by using a four-point assay procedure, whereas the plasma BGH measurements (1 dose level) were determined by using a bracketed three-point assay method (34) . Differences in BGH concentrations between groups were determined by using a Student's t-test. Significance was determined at the P Ͻ 0.05 level for all statistical analyses.
RESULTS

BGH and IGH.
Proximal soleus nerve stimulation decreased plasma and increased pituitary BGH by 63 and 34%, respectively, in fed male rats ( Fig. 2A) . In a separate experiment, proximal stimulation of the sural nerve in fed male rats had no effect on plasma or pituitary BGH, while stimulation of the proximal tibial nerve trunk increased plasma and decreased pituitary BGH by 217 and 68%, respectively (Fig. 2B) . Again, stimulation of the proximal end of the soleus nerve, in contrast, decreased plasma BGH by 60%, whereas increasing pituitary BGH by 54% in fed male rats (Fig.  2B) . Plasma IGH was unchanged in fed male rats after either sural, tibial, or soleus nerve stimulation (Fig. 2,  A and B) .
Stimulation of the proximal end of the severed tibial nerve in fed female rats increased plasma BGH by 295% and decreased pituitary BGH by 45%, with no effect on plasma IGH (Fig. 2C) . Female rats that were deprived of food for ϳ12 h before stimulation had basal plasma hormone and metabolite levels that were significantly different from rats that had been fed throughout (see below). Despite these differences in basal values, the stimulation of individual nerves had effects similar in direction to those found in fed rats. For example, stimulation of the proximal end of the severed sural nerve had no effect on plasma or pituitary BGH or plasma IGH (Fig. 3) . Furthermore, proximal soleus nerve stimulation decreased plasma BGH levels by 81% but had no effect on pituitary BGH or plasma IGH concentrations (Fig. 3) . The lack of an effect of soleus nerve stimulation on pituitary BGH is surprising because there was a clear reduction in plasma BGH, suggesting that secretion was inhibited. Food deprivation may have reduced the ability of the pituitary to release BGH, but more experiments will be needed to clarify this finding.
Other plasma hormones and metabolites. Plasma concentrations of testosterone (male rats), T 3 , T 4 , corticosterone, glucose, lactate, and triglycerides were measured and are summarized in Tables 1 and 2 . Some female rats from which food had been withheld overnight demonstrated significantly higher corticosterone and T 3 levels than did rats that were fed continuously. This finding is not surprising, however, because food deprivation is a stressor. No differences in any of the other hormones or metabolites were seen between any of the stimulation groups and their appropriate controls.
DISCUSSION
Afferent regulation of BGH secretion.
The present data show that the input from a predominantly fast muscle group stimulates, whereas input from an individual slow muscle inhibits, the release of BGH from the rat pituitary. The inhibition of BGH secretion by afferent input from the slow soleus was contrary to our expectations at the onset of these experiments. In fact, we now reject our hypothesis that afferent input from the soleus would increase BGH secretion equal to or greater than that seen after stimulation of the proximal tibial nerve trunk. Results from male and female rats were similar, demonstrating that this BGH response is not gender specific. We also found that even after deprivation of food overnight (for ϳ12 h), which elevated basal plasma BGH, stimulation of the slow muscle nerve still inhibited BGH release.
The neural regulation of BGH secretion appears to be specific to BGH, because no effects on IGH release were seen in any of the nerve stimulation experiments in either male or female rats. Furthermore, no changes were observed in plasma testosterone, T 3 , T 4 , corticosterone, glucose, lactate, or triglyceride levels after stimulation. Because the nerve stimulation paradigm used in the present study was based on electromyogram recordings taken from exercising rats running on a treadmill at ϳ40 m/min and because the nerves were severed before stimulation (i.e., no muscle contractions), we were able to separate the neural from the metabolic effects of muscle activation. The results clearly demonstrate a rapid and specific means of stimulating or inhibiting BGH release mediated by some neural, and not metabolic, mechanism involving afferent input from working skeletal muscles.
The use of a two times threshold stimulation intensity strongly suggests that group I and possibly group II afferents from muscle spindles and/or Golgi tendon organs are one source of BGH regulation. These large afferents have been shown to be activated at low stimulation intensities (28) . The release of BGH was enhanced by afferent input predominantly from fast muscles and inhibited by afferent input from only slow (i.e., soleus) muscle. From the standpoint of the number of muscle afferents that project rostrally, this result is surprising because the soleus has the highest spindle density of any major hindlimb muscle (4) and, therefore, has the most group I and II afferent inputs. It appears, therefore, that different pathways from fast and slow muscles to the site of control of BGH secretion must exist. It should be noted that although the tibial nerve stimulation, which markedly enhanced BGH secretion, primarily involves fast musculature, it also incorporates afferent input from the proximal soleus nerve trunk. Soleus nerve stimulation alone, in contrast, strongly inhibited BGH release. These data indicate that, whereas inputs from fast and slow muscles differ in their ability to regulate BGH release, fast muscle inputs appear to be dominant. Further experiments are needed to clarify the pathway(s) by which afferent input from fast and slow muscle nerves reach the hypothalamus to affect anterior pituitary secretion of BGH.
Neural regulation of the anterior pituitary gland. Data from other laboratories provide further evidence that the anterior pituitary can be neurally regulated in addition to its known humoral regulation. First, nerve tracts have been identified that project from the spinal cord to the hypothalamic paraventricular nucleus. This is a site known to have numerous functions in endocrine regulation, including the regulation of IGH secre- tion by GH-releasing hormone (5, 7) . Second, a number of investigators have demonstrated the presence of nerve fibers within the anterior pituitary gland of the rat. These nerve fibers are immunoreactive for factors involved in pituitary regulation, such as substance P (1, 23, 30) , calcitonin gene-related peptide (12, 22, 23) , somatostatin (23, 35) , and serotonin (26) . Furthermore, these nerve fibers lie in contact with, or in close apposition to, somatotrophs (27, 35) , thyrotrophs (35) , and corticotrophs (22, 24, 27) , and some respond to changes in the overall hormonal state of the animal (e.g., increasing density of varicosities near corticotrophs after adrenalectomy) (22, 24, 27) . Last, a neural mechanism for regulating opioid release from the brain in response to exercise and/or muscle activity has been demonstrated in rats (19) . Specifically, the release of ß-endorphin from the hypothalamic arcuate nucleus and anterior pituitary gland was induced by activation of slow-conducting (group III and IV) afferent nerve fibers from skeletal muscle. The combined results from these experiments are consistent with some neural regulation of the anterior pituitary gland by afferent input from the periphery.
Significance of BGH and a neural mechanism for regulation of its secretion. The existence of a factor, BGH, which is secreted from the anterior pituitary and promotes rat tibial epiphyseal growth in a doseresponse fashion, has been demonstrated. This growth cannot be accounted for by IGH, which is the only hormone or growth factor known to induce dose-related growth of the epiphysis at physiological levels (16) . It has been known for some time that multiple molecular forms of GH, varying in size and physiological action, exist in plasma and are present in and secreted by the anterior pituitary gland (3). Few of these variants are detectable by immunoassay, which is the standard method for measuring GH in plasma. Measuring GH by bioassay, therefore, provides a more complete profile of GH activity in plasma and pituitary tissue and likely takes the activities of more of these variants into account.
Fractionation studies have placed the tibial growthpromoting BGH activity in plasma within the 60-to 80-kDa molecular mass range, far larger than 22-kDa IGH (11) . Furthermore, when IGH is removed from whole-plasma fractions by immunoprecipitation with a polyclonal antibody, that plasma fraction is still able to promote tibial epiphyseal growth at the same level as when IGH is present in the plasma fraction (11) . The sensitivity of the tibial bioassay is ϳ1 µg of IGH (16), but plasma IGH concentrations are only ϳ10 ng/ml or less. Therefore, the contribution of IGH to the growth- Fig. 2B ) is sham operated for tibial nerve; control in experiment 2 (corresponds to Fig. 2A ) is sham operated for sural nerve. T 3 , 3,5,3Ј-triiodothyronine; T 4 , thyroxine; S, stimulated. All rats were fed ad libitum. There were no significant differences in any of the hormones or metabolites between groups within each experiment. Values are means Ϯ SE; n, no. of rats. Results are grouped by separate experiments. Control in experiment 1 (corresponds to Fig. 2C ) is sham operated for tibial nerve; in experiment 2 (corresponds to Fig. 3) , sural-C is sham operated for sural nerve and soleus-C is sham operated for soleus nerve. Rats in experiment 1 were fed ad libitum; rats in experiment 2 were food deprived overnight (for ϳ12 h). There were no significant differences in any of hormones or metabolites between stimulated groups and their appropriate controls within experiments. *Significant differences between experiments (fed vs. food deprived), P Յ 0.05. † Significant difference between soleus-S and sural-S stimulation groups in experiment 2, but neither of these stimulation groups was significantly different from their respective control group, P Ͻ 0.05.
promoting activity of plasma is negligible. Other plasma hormones in addition to IGH that are known to affect tibial growth include testosterone, thyroid hormones (T 3 and T 4 ), and insulin-like growth factor I (16). However, these hormones do not induce epiphyseal widening in a dose-response fashion, nor are they present in plasma at high enough concentrations to affect tibial growth (16) . Furthermore, no changes in plasma testosterone, T 3 , or T 4 were seen after any of the nerve stimulations, demonstrating that the changes in BGH activity between control and stimulated rats cannot be accounted for by these other hormones.
A clinical condition recently has been discovered in which some humans deficient in IGH are still capable of attaining normal stature and body composition (13) . In addition, patients with pseudoacromegaly display acromegalic features, such as thickening of the brow ridge and enlargement of the hands and feet, but have normal or even subnormal circulating levels of IGH in their plasma (2) . Plasma samples from both of these types of individuals have been shown to contain an uncharacterized peptide growth factor with a molecular mass of ϳ70 kDa (13) . This protein is able to induce growth of erythroid progenitor cell colonies in culture, a function that is predominantly stimulated by IGH (2) . All of these results suggest the presence of factors other than IGH that have strong growth-promoting functions.
In summary, the secretion of BGH, but not IGH, from the anterior pituitary gland into the blood can be activated by afferent input from working fast muscles and inhibited by afferent input from working slow muscles. The afferents involved in regulating BGH release appear to be the large, low-threshold, group I and possibly group II fibers originating from the muscle spindles and/or Golgi tendon organs responsible for proprioceptive signaling from the periphery. The secretion of BGH also is altered by changes in proprioception. Specifically, BGH secretion is reduced after unloading of the musculoskeletal system as occurs in spaceflight (21) . Furthermore, BGH is released in rats and humans in response to exercise (14, 15, 17, 29) ; this exercise response is blunted by bed rest, another condition in which the musculoskeletal system is unloaded and proprioception is decreased (29) . The present results also show that this novel regulatory mechanism for BGH is similar in males and females and is present in food-deprived rats when basal plasma BGH levels are elevated, as well as in continuously fed rats.
